1,6-Dioxaspiro[2.5]octane, 95.0%, 25g

N-Boc-2-Propargyl-L-glycine, 95.0%, 10g

5,10,15,20-Tetrakis(4-carboxymethyloxyphenyl)porphyrin, 95%, 250mg

1-(4-Bromo-3-methylphenyl)cyclopropane-1-carbonitrile, 98%, 100mg

GC-Kapillarsäule ROTI®Cap-5, unpolar, L 50 m, Ø-Innen 0,20 mm, Filmd. 0,35 µm, 1 Stück

2-Bromo-4-[(4-methoxyphenyl)methoxy]-1-nitro-benzene, 98%, 100mg

rac 6-Methyl-morpholin-3-one, 98.0%, 1g

Olodaterol Hydrochloride, 95%, 1mg

6-Chloro-N,N-dimethylpyrimidin-4-amine, 95.0%, 1g

(R)-1-(PYRIDIN-3-YL)ETHANAMINE HCL, 95.0%, 100mg

5-methyl-4-(piperazin-1-yl)pyrimidine, 95.0%, 500mg

Tetrachlorophthalonitrile, 95.0%, 1g

3-(BOC-AMINO)-BICYCLO[1.1.1]PENTANE-1-METHANOL, 95.0%, 1g